Eduardo Rene Salas serves as Executive at Intra-Cellular Therapies, Inc., where they oversee executive responsibilities. Since joining the company, Eduardo Rene Salas has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 9, 2026 involved receiving (via award) 17,730 shares valued at $0.
Eduardo Rene Salas currently holds 17,730 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eduardo Rene Salas has been a net neutral trader of ITCI stock. They have purchased $0 and sold $0 worth of shares.
Eduardo Rene Salas's most recent insider trade was on Feb 9, 2026, when they sold 17,730 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 23, 2024 | ITCI | $0 | Option Exercise | 1,567 | $N/A | Discretionary |